Login / Signup

Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report.

Theresa ReutterJana FassunkeMichael PüskenJan-Phillip WeberElke BinotAnna EisertRieke FischerLucia NogovaRichard RiedelDiana SchauflerHeather ScharpenseelMatthias SchefflerHolger SchulzDirk-Thomas WaldschmidtThomas ZanderSabine Merkelbach-BrusePeter SchirmacherReinhard ButtnerJuergen WolfSebastian Michels
Published in: JCO precision oncology (2023)
Keyphrases
  • dna damage
  • case report
  • combination therapy
  • replacement therapy